Ann: Best and Final Confirmation and Bridging Loan, page-86

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 86 Last

Share
Profile

Follow
rotto

295 Posts.

1

16/08/22

20:51

Post #: 63151304
Share

Originally posted by akubra: ↑

All this talk about class action, about getting rid of the board, smells of financially illterate, angry amateurs that do not know how to read a balance sheet.
The situation is simple.I still fail to see any argumented way to create value ALONE grounded in sound hypotheses, some path to growth that is not a pipe dream.
Without Pfizer who is taking a risky moonshot at REApp tech, and procuring a bridge loan, the company will go bankrupt in a matter of a few months.
In this environnement, the worse for biotech in decades, where believe me or not in the Nasdaq about 2/3 of biotech traded below net cash in July, RESapp does not stand a fighting chance to survive ALONE.
Investors in 2022 want 1)proven technologies ,2) derisked companies and 3)multiple shots on goal and 4) cash runway of at least 18 months.
Pfizer stands out as a white knight here and we should count or blessings!
Take 20.8c now, or face a gap down to the 5-9 c area with a NO vote, then a donut , an ASX delisting and ultimately Pfizer will bid for the tech assets at a fraction of the price in the bankruptcy auctions in a few quarters.

Expand

unfortunately I totally agree on all points I am so angry that this has come to a sorry conclusion
The BOD s are the instrument All of these one direction decisions should have all been voted on by SH before.any was signed off

RAP Price at posting: 18.0¢ Sentiment: Sell Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint